GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Cyclically Adjusted Price-to-FCF

Diasorin SpA (LTS:0GZX) Cyclically Adjusted Price-to-FCF : 19.15 (As of Jun. 07, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Cyclically Adjusted Price-to-FCF?

As of today (2024-06-07), Diasorin SpA's current share price is €100.55. Diasorin SpA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €5.25. Diasorin SpA's Cyclically Adjusted Price-to-FCF for today is 19.15.

The historical rank and industry rank for Diasorin SpA's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LTS:0GZX' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 15.99   Med: 40.92   Max: 80.8
Current: 19.34

During the past years, Diasorin SpA's highest Cyclically Adjusted Price-to-FCF was 80.80. The lowest was 15.99. And the median was 40.92.

LTS:0GZX's Cyclically Adjusted Price-to-FCF is ranked better than
69.84% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 35.48 vs LTS:0GZX: 19.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Diasorin SpA's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €1.405. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €5.25 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Diasorin SpA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Diasorin SpA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Cyclically Adjusted Price-to-FCF Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.16 57.57 45.84 27.99 18.27

Diasorin SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.75 19.54 17.30 18.27 17.19

Competitive Comparison of Diasorin SpA's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Diasorin SpA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Cyclically Adjusted Price-to-FCF falls into.



Diasorin SpA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Diasorin SpA's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=100.55/5.25
=19.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Diasorin SpA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.405/120.2000*120.2000
=1.405

Current CPI (Mar. 2024) = 120.2000.

Diasorin SpA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.211 100.093 0.253
201409 0.598 99.814 0.720
201412 0.356 99.721 0.429
201503 0.625 99.814 0.753
201506 0.391 100.279 0.469
201509 0.737 100.000 0.886
201512 0.766 99.814 0.922
201603 0.615 99.600 0.742
201606 0.627 99.900 0.754
201609 0.904 100.100 1.086
201612 0.877 100.300 1.051
201703 0.935 101.000 1.113
201706 0.471 101.100 0.560
201709 0.893 101.200 1.061
201712 0.750 101.200 0.891
201803 0.679 101.800 0.802
201806 0.928 102.400 1.089
201809 0.823 102.600 0.964
201812 1.399 102.300 1.644
201903 0.878 102.800 1.027
201906 0.817 103.100 0.953
201909 1.495 102.900 1.746
201912 1.124 102.800 1.314
202003 1.018 102.900 1.189
202006 0.906 102.900 1.058
202009 0.906 102.300 1.065
202012 3.637 102.600 4.261
202103 1.859 103.700 2.155
202106 1.313 104.200 1.515
202109 2.327 104.900 2.666
202112 1.819 106.600 2.051
202203 2.456 110.400 2.674
202206 0.843 112.500 0.901
202209 2.359 114.200 2.483
202212 1.539 119.000 1.555
202303 0.766 118.800 0.775
202306 1.959 119.700 1.967
202309 1.501 120.300 1.500
202312 1.605 119.700 1.612
202403 1.405 120.200 1.405

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Diasorin SpA  (LTS:0GZX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Diasorin SpA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA (LTS:0GZX) Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.

Diasorin SpA (LTS:0GZX) Headlines

No Headlines